Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study

              Author:Sarva, Harini   Tagliati, Michele   Poewe, Werner   Stocchi, Fabrizio   Rascol, Olivier   Yardeni, Tami   Lopes, Nelson   Pereira, Jonathan   Espay, Alberto   

              Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

              Topic:Movement Disorders  

              Program Number:P11.007  

              Author Institution:Weill Cornell Medical Center, New York, NY  Cedars-Sinai Medical Center, Movement Disorder Program, Los Angeles, CA  Department of Neurology, Medical University Innsbruck, Innsbruck, Austria  University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy  University of Toulouse 3, University Hospital of Toulouse, INSERM  Clinical Investigation Center CIC1436 Departments of Neurosciences and Clinical Pharmacology and NS-Park/FCRIN network, Toulouse, France  NeuroDerm Ltd. , Rehovot, Israel  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  James J and Joan A Gardner Center for Parkinson’s disease and Movement, University of Cincinnati, Cincinnati, OH